Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Share-based Compensation (2016 - 2026)

Standard Biotools has reported Share-based Compensation over the past 16 years, most recently at $4.8 million for Q4 2025.

  • Quarterly Share-based Compensation fell 16.72% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.7 million through Dec 2025, up 5.03% year-over-year, with the annual reading at $25.8 million for FY2025, 48.03% up from the prior year.
  • Share-based Compensation was $4.8 million for Q4 2025 at Standard Biotools, down from $7.5 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $11.7 million in Q3 2021 and troughed at $1.7 million in Q4 2022.
  • The 5-year median for Share-based Compensation is $4.6 million (2024), against an average of $5.4 million.
  • Year-over-year, Share-based Compensation crashed 61.71% in 2022 and then soared 268.84% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $11.7 million in 2021, then crashed by 85.68% to $1.7 million in 2022, then skyrocketed by 106.72% to $3.5 million in 2023, then skyrocketed by 66.45% to $5.8 million in 2024, then decreased by 16.72% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Share-based Compensation are $4.8 million (Q4 2025), $7.5 million (Q3 2025), and $5.4 million (Q2 2025).